// App-Quantinova.ai

BSH19‐EP‐033 : Molecular remissions are observed in chronic adult T‐cell leukaemia/lymphoma in patients treated with mogamulizumab

Researchers

Presenter

  • L. Cook

Principal Investigators

  • M.A. Demontis

  • S. Sagawe

  • A. Witkover

  • A. Melamed

  • J. Turpin

  • J. Haddow

  • S. Wolf

  • S. Marks

  • C. Bangham

  • P. Fields

  • G. Taylor

  • A. Rowan

Medical Centers

  • Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital

  • National Centre for Human Retrovirology, Imperial College Healthcare NHS Trust, St Mary's Hospital

  • Skin Tumour Unit, Guys’ Hospital

  • Section of Virology, Imperial College London

  • Department of Virology, Royal Free Hospital, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Adult T-Cell Leukemia

Biomarkers

  • C-C Motif Chemokine Receptor 4

Drug/Treatment

  • Mogamulizumab

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved